GW&K Investment Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-554,288
| Closed | -$6.19M | – | 641 |
|
2022
Q4 | $6.19M | Sell |
554,288
-10,568
| -2% | -$118K | 0.06% | 247 |
|
2022
Q3 | $3.17M | Buy |
564,856
+100,473
| +22% | +$565K | 0.04% | 271 |
|
2022
Q2 | $2.01M | Buy |
464,383
+10,216
| +2% | +$44.2K | 0.02% | 307 |
|
2022
Q1 | $5.29M | Buy |
454,167
+83,383
| +22% | +$971K | 0.05% | 247 |
|
2021
Q4 | $6.77M | Sell |
370,784
-17,946
| -5% | -$328K | 0.06% | 240 |
|
2021
Q3 | $4.61M | Sell |
388,730
-5,483
| -1% | -$65K | 0.04% | 272 |
|
2021
Q2 | $6.78M | Sell |
394,213
-8,070
| -2% | -$139K | 0.06% | 247 |
|
2021
Q1 | $7.35M | Buy |
402,283
+51,357
| +15% | +$939K | 0.07% | 235 |
|
2020
Q4 | $6.6M | Buy |
350,926
+68,219
| +24% | +$1.28M | 0.07% | 244 |
|
2020
Q3 | $5.97M | Buy |
282,707
+127,274
| +82% | +$2.69M | 0.08% | 235 |
|
2020
Q2 | $4.49M | Buy |
+155,433
| New | +$4.49M | 0.06% | 241 |
|